B.ShahN
The table shows that resmetirom is a small (molecular weight about 600 g/mol), non-iodinated THR- agonist administered once daily as an oral tablet, while semaglutide is a large (about 4 kDa) GLP-1 peptide designed for once-weekly subcutaneous injection or, with SNAC enhancement, once-daily oral administration
De Tullio et al., 2003
Freeze-thaw cycling is especially destructive to peptides each cycle forms ice crystals that physically shear the molecule, so even one accidental freeze can tank a vial
What works well: Fast absorption with no digestive breakdown, making it one of the more efficient delivery methods available
Liraglutide treatment in this model has alleviated cardiometabolic dysregulation and enhanced cardiac function, resulting in reduced cardiac hypertrophy and fibrosis, as well as diminished atrial weight, natriuretic peptide levels, and lung congestion [84]